No Link Between Heartburn Drugs and Birth Defects:
WEDNESDAY, Nov. 24 (HealthDay News) -- Babies born to women who
took a popular class of heartburn drugs while they were pregnant
did not appear to have any heightened risk of birth defects, a
large Danish study finds.
This class of drugs, known as proton-pump inhibitors (PPIs),
include blockbusters such as Prilosec (omeprazole), Prevacid
(lansoprazole) and Nexium (esomeprazole). All were available by
prescription-only during most of the study period (1996-2008), but
Prilosec and Prevacid are now sold over-the-counter.
While the authors and an editorialist, publishing in the Nov. 25
issue of the
New England Journal of Medicine, called the results "reassuring," experts still recommend using drugs as little as possible during pregnancy.
"In general, these are probably safe but it takes a lot of time and a lot of exposures before you see some of the abnormalities that might exist," explained Dr. Eva Pressman, professor of obstetrics and gynecology and director of maternal-fetal medicine at the University of Rochester Medical Center. "My recommendations are always to avoid medication exposure if at all possible. There are very few life-threatening disorders that require these PPIs," she noted.
"There are other ways to get the same effect," added Pressman, who was not involved in the study. "Most pregnant women have heartburn but most of it is relatively easy to treat with simple antacids such as Tums and Maalox and Mylanta, all of which are locally acting and absorbed, and don't pose any risk to the fetus."
Even propping yourself up so you're in a semi-vertical position,
as opposed to lying flat, can help, said Dr. Michael Katz, senior
vice president for research and global programs at the March of
The research was funded by the Danish Medical Research Council
and the Lundbeck Foundation.
The authors of the new study used linked databases to glean
information on almost 841,000 babies born in Denmark from 1996
through 2008, as well as on the babies' mothers' use of PPIs during
PPI use by expectant women was the highest between 2005 and
2008, when about 2 percent of fetuses were exposed, but exposure
during the critical first trimester was less than 1 percent.
Babies were followed until they were one year old.
The proportion of babies with birth defects hovered at about 3
percent in both groups -- 3.4 percent of those who had been exposed
to a PPI in utero, and 2.6 percent for unexposed babies.
In an unexpected finding, there was a 39 percent increased risk
of major birth defects among children whose mothers had taken PPIs
in the month
before conception, a finding the authors are attributing to
either chance or to another factor, perhaps the reason the mother
was taking the medication in the first place. This could have been
Helicobacter pylori, the bacteria that causes most ulcers.
In addition to Prilosec, Prevacid and Nexium, the authors also
looked at Aciphex (rabeprazole) and Protonix (pantoprazole).
Prilosec was the only drug not associated with an increase in
birth defects when taken during the month before conception,
leading the editorial author to suggest this drug as a first line
A related journal editorial, written by Dr. Allen A. Mitchell,
director of the Slone Epidemiology Center at Boston University
School of Medicine, also noted some caveats. These included the
fact that even this big of a sample may not have been large enough
to detect specific birth defects (such as heart defects) or to
ascertain the effect of specific drugs within the class. Nor can
the influence of other factors be ruled out, Mitchell wrote.
Perhaps folic-acid supplementation during pregnancy is hiding the
true effects of the PPIs, Mitchell said.
The bottom line, according to the experts, is that it's still
not clear whether these drugs are safe or not for pregnant
"Having negative observations is never absolutely reassuring," Katz said. "All you can say is that within that range [in this case, 800,000 infants], the probability is that it is safe," he explained.
"The balance in pragmatic terms is how important is it to treat the symptoms that any drug is designed to treat versus the safety of pregnancy," he added. "That's a very difficult decision to make."
There's more on pregnancy and birth defects at the
Copyright © 2010
. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.